ereprof. dr. August Verbruggen

Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis

Féline PB Kroon, Anne C Bay-Jensen, Ruth Wittoek (UGent) , August Verbruggen (UGent) , Joseph S Smolen, Margreet Kloppenburg and Roberta Ramonda

(2020) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 49(2). p.167-168

Add to list

Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial

Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Dirk Elewaut (UGent) , Tom WJ Huizinga, Feline PB Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen (UGent) , et al.

(2018) ANNALS OF THE RHEUMATIC DISEASES. 77(12). p.1757-1764

Add to list

Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study

Ruth Wittoek (UGent) , Philippe Carron (UGent) , Bieke Lambert (UGent) , Paulien Meersseman, August Verbruggen (UGent) , Filip Van den Bosch (UGent) and Dirk Elewaut (UGent)

(2018) ANNALS OF THE RHEUMATIC DISEASES. 77(2). p.310-311

Add to list

Journal Article
A1
open access

99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study

Bieke Lambert (UGent) , Philippe Carron (UGent) , Yves D'Asseler (UGent) , Klaus Bacher (UGent) , Filip Van den Bosch (UGent) , Dirk Elewaut (UGent) , August Verbruggen (UGent) , Rudi Beyaert (UGent) , Caroline Dumolyn (UGent) and Filip De Vos (UGent)

(2016) EJNMMI RESEARCH. 6.

Add to list

Clinical and radiological factors associated with erosive radiographic progression in hand osteoarthritis

Paulien Meersseman, Celine Van de Vyver, August Verbruggen (UGent) , Dirk Elewaut (UGent) and Ruth Wittoek (UGent)

(2015) OSTEOARTHRITIS AND CARTILAGE. 23(12). p.2129-2133

Add to list

Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients

Philippe Carron (UGent) , Bieke Lambert (UGent) , Filip De Vos (UGent) , August Verbruggen (UGent) , Dirk Elewaut (UGent) and Filip Van den Bosch (UGent)

(2014) ARTHRITIS & RHEUMATOLOGY. 66(suppl. 10). p.S933-S933

Add to list

Selecting patients with spondyloarthritis (SpA) or rheumatoid arthritis (RA) for antiTNF-alfa treatment: first scintigraphic data with Tc99m-labelled certolizumab pegol

Philippe Carron (UGent) , Bieke Lambert (UGent) , Filip Van den Bosch (UGent) , Dirk Elewaut (UGent) , August Verbruggen (UGent) , Lennart Jans (UGent) , Yves D'Asseler (UGent) and Filip De Vos (UGent)

(2013) Society of Nuclear Medicine and Molecular Imaging, Annual meeting, Abstracts.

Add to list

Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis

Philippe Carron (UGent) , Bieke Lambert (UGent) , Filip De Vos (UGent) , August Verbruggen (UGent) , Dirk Elewaut (UGent) and Filip Van den Bosch (UGent)

(2013) ARTHRITIS AND RHEUMATISM. 65(suppl. 10). p.S472-S472

Add to list

99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study

Bieke Lambert (UGent) , Philippe Carron (UGent) , Yves D'Asseler (UGent) , Klaus Bacher (UGent) , Filip Van den Bosch (UGent) , Lennart Jans (UGent) , Dirk Elewaut (UGent) , August Verbruggen (UGent) and Filip De Vos (UGent)

(2013) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 40(suppl. 2). p.S392-S392

Add to list

3 T DCE-MRI assessment of synovitis of the interphalangeal joints in patients with erosive osteoarthritis for treatment response monitoring

Lennart Jans (UGent) , Tineke De Coninck (UGent) , Ruth Wittoek (UGent) , Valerie Lambrecht (UGent) , Wouter Huysse (UGent) , August Verbruggen (UGent) and Koenraad Verstraete (UGent)

(2013) SKELETAL RADIOLOGY. 42(2). p.255-260

Academic Bibliography

ereprof. dr. August Verbruggen

Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis

Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial

Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study

99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study

Clinical and radiological factors associated with erosive radiographic progression in hand osteoarthritis

Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients

Selecting patients with spondyloarthritis (SpA) or rheumatoid arthritis (RA) for antiTNF-alfa treatment: first scintigraphic data with Tc99m-labelled certolizumab pegol

Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis

99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study

3 T DCE-MRI assessment of synovitis of the interphalangeal joints in patients with erosive osteoarthritis for treatment response monitoring

Contents

Support

Contact